$FXC
Invesco CurrencyShares Canadian Dollar Trust

2024 Q3 Form 10-Q Financial Statement

#000095017024122607 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $362.0K
YoY Change -34.63%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $61.92K
YoY Change -24.43%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $300.1K
YoY Change -36.4%
Net Earnings / Revenue 82.89%
Basic Earnings Per Share $0.35
Diluted Earnings Per Share $0.35
COMMON SHARES
Basic Shares Outstanding 860.9K
Diluted Shares Outstanding 860.9K

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $61.49M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $61.60M
YoY Change -19.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $22.72K
YoY Change -27.31%
SHAREHOLDERS EQUITY
Retained Earnings $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $61.60M
YoY Change -19.03%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $300.1K
YoY Change -36.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $311.2K
YoY Change -33.5%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001353612
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Invesco CURRENCYSHARES CANADIAN DOLLAR TRUST
CY2024Q3 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32910
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-6551776
dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
983-0903
dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
dei Trading Symbol
TradingSymbol
FXC
dei Security Exchange Name
SecurityExchangeName
NYSEArca
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
850000
CY2024Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
61492087
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
77824405
CY2024Q3 us-gaap Due From Banks
DueFromBanks
0
CY2023Q4 us-gaap Due From Banks
DueFromBanks
1716
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
112034
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
182689
CY2024Q3 us-gaap Assets
Assets
61604121
CY2023Q4 us-gaap Assets
Assets
78008810
CY2024Q3 us-gaap Noninterest Bearing Deposit Liabilities Foreign
NoninterestBearingDepositLiabilitiesForeign
2069
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Foreign
NoninterestBearingDepositLiabilitiesForeign
0
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20653
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
26141
CY2024Q3 us-gaap Liabilities
Liabilities
22722
CY2023Q4 us-gaap Liabilities
Liabilities
26141
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2024Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
850000
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
850000
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1050000
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1050000
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
61581399
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
77982669
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61604121
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78008810
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
361987
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
553719
us-gaap Investment Income Interest
InvestmentIncomeInterest
1222131
us-gaap Investment Income Interest
InvestmentIncomeInterest
1687589
CY2024Q3 us-gaap Revenues
Revenues
361987
CY2023Q3 us-gaap Revenues
Revenues
553719
us-gaap Revenues
Revenues
1222131
us-gaap Revenues
Revenues
1687589
CY2024Q3 us-gaap Sponsor Fees
SponsorFees
61921
CY2023Q3 us-gaap Sponsor Fees
SponsorFees
81935
us-gaap Sponsor Fees
SponsorFees
186076
us-gaap Sponsor Fees
SponsorFees
277090
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
61921
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
81935
us-gaap Operating Expenses
OperatingExpenses
186076
us-gaap Operating Expenses
OperatingExpenses
277090
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
300066
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
471784
us-gaap Net Income Loss
NetIncomeLoss
1036055
us-gaap Net Income Loss
NetIncomeLoss
1410499
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.11
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
860870
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
860870
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1108696
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1108696
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
863869
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
863869
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1268498
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1268498
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
311157
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
300066
CY2024Q3 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
11091
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
467919
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
471784
CY2023Q3 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-3865
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1080512
us-gaap Net Income Loss
NetIncomeLoss
1036055
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
44457
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1368673
us-gaap Net Income Loss
NetIncomeLoss
1410499
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-41826
us-gaap Net Income Loss
NetIncomeLoss
1036055
us-gaap Net Income Loss
NetIncomeLoss
1410499
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-70655
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
24815
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-5488
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-8353
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1101222
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1377331
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
1080512
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
1368673
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
21469947
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
68494921
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
36155840
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
90926263
us-gaap Net Change Noninterest Bearing Deposits Foreign
NetChangeNoninterestBearingDepositsForeign
2069
us-gaap Net Change Noninterest Bearing Deposits Foreign
NetChangeNoninterestBearingDepositsForeign
1282
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15764336
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23798733
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1670920
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
947607
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16334034
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21473795
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77826121
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97375615
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61492087
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75901820
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-06-08
CY2024Q3 fxc Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
100
fxc Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
fxc Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B. Accounting Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.36
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.42
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.25
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.08
CY2024Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
311157
CY2023Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
467919
us-gaap Payments Of Dividends
PaymentsOfDividends
1080512
us-gaap Payments Of Dividends
PaymentsOfDividends
1368673
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2024-10-07
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2024-10-01
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10484
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
89114
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
fxc Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2024Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0211
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
29319800
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
48866326
CY2024Q3 us-gaap Cash
Cash
83072734
CY2024Q3 us-gaap Cash
Cash
61492087
CY2023 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
141712275
CY2023 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
171032104
CY2023Q4 us-gaap Cash
Cash
102619260
CY2023Q4 us-gaap Cash
Cash
77824405
fxc Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 fxc Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 fxc Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-122607-index-headers.html Edgar Link pending
0000950170-24-122607-index.html Edgar Link pending
0000950170-24-122607.txt Edgar Link pending
0000950170-24-122607-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fxc-20240930.htm Edgar Link pending
fxc-20240930.xsd Edgar Link pending
fxc-ex31_1.htm Edgar Link pending
fxc-ex31_2.htm Edgar Link pending
fxc-ex32_1.htm Edgar Link pending
fxc-ex32_2.htm Edgar Link pending
img30774178_0.jpg Edgar Link pending
img30774178_1.jpg Edgar Link pending
img30774178_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fxc-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable